Amyloid A as a biomarker for preeclampsia | ||||
Evidence Based Women's Health Journal | ||||
Article 4, Volume 10, Issue 1, February 2020, Page 27-30 PDF (784.21 K) | ||||
Document Type: Original Article | ||||
DOI: 10.21608/ebwhj.2019.17675.1035 | ||||
![]() | ||||
Authors | ||||
Mohamed Ahmed El-Kady1; Dina Yahia Ali1; Noha Hussein Boshnak2; SALMA AHMED ![]() | ||||
1Department of Obstetrics and Gynecology, Faculty of Medicine, Ain-Shams University, Cairo, Egypt | ||||
2Department of Clinical Pathology, Faculty of Medicine, Ain-Shams University, Cairo, Egypt | ||||
3Faculty of Medicine - Ain shams University | ||||
Abstract | ||||
Aim:To investigate and evaluate serum levels of amyloid A in PET and healthy gestations, to help in detection of a correlation between PET and serum levels of amyloid A. Methodology: A randomized case control research study conducted at Ain-Shams University Maternity Hospital, Cairo, Egypt in a period of 6 months. There was 102 study subjects in the total cohort ; 51 cases diagnosed with preeclampsia and 51 study subjects with normal gestations as a control research group. Results: The median serum level of amyloid-A was statistically significantly higher in women of PE research group in comparison to women of the control research group (p value | ||||
Keywords | ||||
Amyloid A; biomarker; preeclampsia | ||||
Statistics Article View: 444 PDF Download: 551 |
||||